Work With Your Doctor to Get Breyanzi (Lisocabtagene Maraleucel) Approved by UnitedHealthcare in Florida: Complete Provider Collaboration Guide
Quick Answer: Getting Breyanzi Approved in Florida
Breyanzi (lisocabtagene maraleucel) requires UnitedHealthcare prior authorization for relapsed/refractory large B-cell lymphoma or CLL/SLL after ≥2 prior therapies. Your oncologist must submit documentation showing progression after standard treatments, confirm CD19 positivity, and demonstrate you meet FDA labeling criteria. Treatment must occur